RxDoctor Payments DataLook up a doctor →

Robert Hozman, MD

Rheumatology · Skokie, ILNPI 1659308237

Payments from drug & device makers

$3,180,610in general payments, 2019–2025

Across 3,777 payments — averaging $842.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.6M
  • Amgen$374K
  • Janssen Research & Development, LLC$245K
  • E.r. Squibb & Sons, L.L.C.$243K
  • GSK$199K
  • UCB SA$156K
  • plus $372K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)908$1,591,456
Amgen(2 entities)593$373,588
Janssen Research & Development, LLC24$245,143
E.r. Squibb & Sons, L.L.C.114$243,478
GSK258$198,833
UCB SA17$155,811
Sun Pharmaceutical Industries Inc.145$135,699
Novartis227$72,087
Takeda Pharmaceuticals U.S.A., Inc.66$50,841
Bristol Myers Squibb28$29,769
Kiniksa Pharmaceuticals International, PLC8$19,749
Pfizer219$15,083
Eli Lilly5$14,477
Vertex1$8,841
AstraZeneca(2 entities)172$4,199
Johnson & Johnson(2 entities)66$3,346
UCB, Inc.172$3,346
Mallinckrodt Hospital Products Inc.142$2,240
Boehringer Ingelheim100$1,926
Novo Nordisk99$1,737
ANI Pharmaceuticals, Inc.37$1,219
Lilly USA, LLC52$1,166
Octapharma USA, Inc.16$1,023
Sanofi32$703
Hikma Pharmaceuticals USA29$403
Biohaven Pharmaceutical Holding Company Ltd.30$398
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$392
Supernus Pharmaceuticals, Inc.22$346
Radius Health, Inc.16$294
Janssen Scientific Affairs, LLC2$287
Hospira, Inc.13$259
Mallinckrodt Enterprises LLC13$242
Ironwood Pharmaceuticals, Inc15$222
Biohaven Pharmaceuticals, Inc.17$192
Aurinia Pharma U.S., Inc.8$165
Lundbeck LLC8$145
Genentech USA, Inc.6$121
Bio Products Laboratory USA, Inc.5$112
Teva Pharmaceuticals USA, Inc.6$97
Corcept Therapeutics4$95
Sandoz5$94
Sanofi-aventis U.S. LLC3$92
Fidia Pharma USA Inc.5$92
Fresenius Kabi USA, LLC4$89
Ultragenyx Pharmaceutical Inc.5$88
Merck5$74
Biocon Biologics Inc3$63
Tersera Therapeutics LLC3$63
Antares Pharma, Inc.3$52
Medexus Pharma, Inc.4$51
Arcutis Biotherapeutics, Inc.2$41
Eyevance Pharmaceuticals LLC3$40
Amarin Pharma, Inc.2$38
Eisai Inc.2$37
Kowa Pharmaceuticals America, Inc.2$32
Actelion Pharmaceuticals US, Inc.2$31
Avanos Medical1$18
Orthogenrx Inc.1$17
Boston Scientific1$15
Sebela Pharmaceuticals Inc.1$14

How this compares

$3,180,610 in reported general payments places this provider in the 95th percentile of 287 rheumatology providers in Illinois.

See all rheumatology providers in Illinois →

Medicare billing

Part B allowed, 2024
$131,509
Medicare patients
361
Services billed
1,364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Skokie

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →